Compounds > valine

valine and Parkinson Disease, Secondary

valine has been researched along with Parkinson Disease, Secondary in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Akbar, U; Friedman, JH; Kim, DS1
Blanchet, PJ; Chase, TN; Konitsiotis, S; Whittemore, ER; Woodward, RM; Zhou, ZL1

Other Studies

2 other study(ies) available for valine and Parkinson Disease, Secondary

ArticleYear
Valbenazine-induced parkinsonism.
    Parkinsonism & related disorders, 2020, Volume: 70

    Topics: Adrenergic Uptake Inhibitors; Adult; Affective Disorders, Psychotic; Aged; Antipsychotic Agents; Female; Humans; Male; Parkinson Disease, Secondary; Tardive Dyskinesia; Tetrabenazine; Valine; Vesicular Monoamine Transport Proteins

2020
Differing effects of N-methyl-D-aspartate receptor subtype selective antagonists on dyskinesias in levodopa-treated 1-methyl-4-phenyl-tetrahydropyridine monkeys.
    The Journal of pharmacology and experimental therapeutics, 1999, Volume: 290, Issue:3

    Topics: Animals; Antiparkinson Agents; Dopamine Agents; Dyskinesia, Drug-Induced; Excitatory Amino Acid Antagonists; Female; Levodopa; Macaca fascicularis; Male; MPTP Poisoning; Oocytes; Parkinson Disease, Secondary; Rats; Receptors, N-Methyl-D-Aspartate; Valine; Xenopus laevis

1999